Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Blake, Cassels & Graydon (U.S.) LLP

We opened our New York office in 2004 to assist U.S. based clients wishing to conduct business in Canada, whether by building, investing in, or acquiring and operating Canadian businesses. We also assist our Canadian clients conducting business in the U.S., including facilitating access to the U.S. capital markets. Our New York office maintains a corporate finance, mergers and acquisitions, securities regulation and financial services practice providing Canadian legal advice to U.S. and international corporations, financial institutions, venture capital and private equity investors, investment dealers and professional advisers.


Contact Details:
65 East 55th StreetSuite 2304, Park Avenue Tower
New York
New York
10022
United States of America
Tel:212-893-8200
Fax:212-829-9500
Email:newyork@blakes.com
WWW:

www.blakes.com/




Loading...

Recent Publications by Blake, Cassels & Graydon (U.S.) LLP:

Sweeping "new" proposed consumer product safety legislation.
The purpose of this study was to evaluate pluronic F127 for the controlled...
26th August, 2009
Blake, Cassels Health Law Can. 2009 May;29(3):52-4.
The Canadian perspective: trends in drug and medical device class actions in Canada.
The purpose of this study was to evaluate pluronic F127 for the controlled...
30th September, 2006
Blake, Cassels & Graydon LLP, Toronto, Canada. Food Drug Law J. 2006;61(3):569-76.
Amendments to the Canadian Patent Act to address drug access: is help on the way?
The purpose of this study was to evaluate pluronic F127 for the controlled...
15th December, 2005
Blake, Cassels & Graydon LLP, Toronto, Canada. Food Drug Law J. 2005;60(3):459-70.
The Canadian approach to freedom of expression and the regulation of food and drug advertising.
The purpose of this study was to evaluate pluronic F127 for the controlled...
3rd December, 2003
Blake, Cassels & Graydon LLP, Toronto, Ontario, Canada. Food Drug Law J. 2003;58(3):521-36.

BioNews Results for Blake, Cassels & Graydon (U.S.) LLP:

Mavrix Fund Management Inc. is Pleased to Announce the Second Closing for the Mavrix Quebec 2009 Flow Through
Genetic Engineering News:  Oct 29 2009 6:53PM Matching: blake cassels

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 209 times since April 2007, the link to the organisation's website has been followed 49 times

Search for more companies in New York

Search for more companies in New York



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Blake, Cassels & Graydon (U.S.) LLP

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.